Clinical trials
Recruiting Phase 1 Esophageal Squamous Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| IDEAYA Biosciences | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
| ALX Oncology Inc. | 1 |
| AbbVie | 1 |
| Affiliated Cancer Hospital of Shantou University Medical College | 1 |
| Coherus Oncology, Inc. | 1 |
| EvolveImmune United, Inc | 1 |
| Exelixis | 1 |
| Kivu Bioscience Inc. | 1 |
| MacroGenics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 18 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Squamous Cell Carcinoma of Head and Neck | 8 |
| Neoplasm Metastasis | 7 |
| Colorectal Neoplasms | 5 |
| Stomach Neoplasms | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Urinary Bladder Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.